Literature DB >> 32383250

The Progress and Prospect of Zeolitic Imidazolate Frameworks in Cancer Therapy, Antibacterial Activity, and Biomineralization.

Aziz Maleki1,2, Mohammad-Ali Shahbazi1,3, Vajiheh Alinezhad1, Hélder A Santos3,4.   

Abstract

The progressive development of zeolitic imidazolate frameworks (ZIFs), as a subfamily of metal-organic frameworks (MOFs), and their unique features, including tunable pore size, large surface area, high thermal stability, and biodegradability/biocompatibility, have made them attractive in the field of biomedicine, especially for drug delivery and biomineralization applications. The high porosity of ZIFs gives them the opportunity for encapsulating a high amount of therapeutic drugs, proteins, imaging cargos, or a combination of them to construct advanced multifunctional drug delivery systems (DDSs) with combined therapeutic and imaging capabilities. This review summarizes recent strategies on the design and fabrication of ZIF-based nansystems and their exploration in the biomedical field. First, recent developments for the adjustment of particle size, functionality, and morphology of ZIFs are discussed, which are important for achieving optimized therapeutic/theranostic nanosystems. Second, recent trends on the application of ZIF nanocarriers for the loading of diverse cargos, including anticancer medicines, antibiotic drugs, enzymes, proteins, photosensitizers, as well as imaging and photothermal agents, are investigated in order to understand how multifunctional DDSs can be designed based on the ZIF nanoparticles to treat different diseases, such as cancer and infection. Finally, prospects on the future research direction and applications of ZIF-based nanomedicines are discussed.
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  ZIF nanoparticles; antibacterial therapies; biomineralization; cancer therapies; metal-organic frameworks

Mesh:

Substances:

Year:  2020        PMID: 32383250     DOI: 10.1002/adhm.202000248

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  4 in total

Review 1.  Recent developments on MOF-based platforms for antibacterial therapy.

Authors:  Yiwei Liu; Luyi Zhou; Ying Dong; Rui Wang; Ying Pan; Shuze Zhuang; Dong Liu; Jianqiang Liu
Journal:  RSC Med Chem       Date:  2021-04-09

2.  Synthesis and Encapsulation of Ajuga parviflora Extract with Zeolitic Imidazolate Framework-8 and Their Therapeutic Action against G+ and G- Drug-Resistant Bacteria.

Authors:  Ab Majeed Ahanger; Suresh Kumar; Atul Arya; Amrita Suryavanshi; Dolly Kain
Journal:  ACS Omega       Date:  2022-01-06

3.  Hybrid Nanoparticles for Haloperidol Encapsulation: Quid Est Optimum?

Authors:  Sergey K Filippov; Ramil R Khusnutdinov; Wali Inham; Chang Liu; Dmitry O Nikitin; Irina I Semina; Christopher J Garvey; Shamil F Nasibullin; Vitaliy V Khutoryanskiy; Hongbo Zhang; Rouslan I Moustafine
Journal:  Polymers (Basel)       Date:  2021-11-30       Impact factor: 4.329

4.  Design of ZIF-based hybrid nanoparticles with hyaluronic acid-augmented ROS behavior for dual-modality PA/NIR-II FL imaging.

Authors:  Botao Qu; Yahong Han; Juan Li; Qian Wang; Bingyu Zhao; Xiaoyang Peng; Ruiping Zhang
Journal:  RSC Adv       Date:  2021-01-27       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.